iCoreConnect Inc. (NASDAQ:ICCT) Short Interest Up 450.1% in February

iCoreConnect Inc. (NASDAQ:ICCT) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 254,700 shares, a growth of 450.1% from the February 13th total of 46,300 shares. Based on an average daily volume of 1,010,000 shares, the days-to-cover ratio is currently 0.3 days. Currently, 18.1% of the company’s shares are short sold.

Institutional Trading of iCoreConnect

A hedge fund recently bought a new stake in iCoreConnect stock. Virtu Financial LLC acquired a new position in iCoreConnect Inc. (NASDAQ:ICCT) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 12,698 shares of the company’s stock, valued at approximately $32,000. Virtu Financial LLC owned 1.04% of iCoreConnect as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 13.42% of the company’s stock.

iCoreConnect Trading Down 2.1 %

Shares of NASDAQ:ICCT traded down $0.02 during trading on Wednesday, reaching $0.71. 818,891 shares of the company traded hands, compared to its average volume of 321,980. The firm has a market capitalization of $1.48 million, a price-to-earnings ratio of -0.01 and a beta of 1.09. iCoreConnect has a 52-week low of $0.61 and a 52-week high of $35.80. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 7.93. The business’s fifty day moving average is $2.03 and its 200-day moving average is $4.55.

iCoreConnect Company Profile

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.